Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 101 - 150 out of 9,373

Document Document Title
WO/2022/252404A1
Provided in the present invention are a fluorosulfonyl free radical reagent, and a preparation method therefor and the use thereof, belonging to the technical field of organic synthesis. The fluorosulfonyl free radical reagent provided b...  
WO/2022/254047A1
The invention generally relates to emodin derivatives of general structure (I), to pharmaceutical compositions comprising same and to their uses in medicine, especially in the treatment of bacterial or viral infections. The invention fur...  
WO/2022/253907A1
The invention provides a pharmaceutically acceptable salt of 5-[[5-[4-(4-fluoro-1-methyl-4-piperidyl)-2-methoxy-phenyl]-1 H-pyrazol-3-yl]amino]pyrazine-2-carbonitrile which is selected from maleate, tosylate, besylate and malonate salts....  
WO/2022/237904A1
A naphthalene ring-containing compound, a pharmaceutical composition containing same, and the use thereof. A naphthalene ring-containing compound as represented by formula III, a pharmaceutically acceptable salt thereof, a solvate thereo...  
WO/2022/233282A1
Disclosed are a polysulfonic acid compound and an intermediate and an application thereof. The polysulfonic acid compound is as represented by formula I-1 or I-2 .Under the catalysis of the compound, the asymmetric hydrogenation alkoxy c...  
WO/2022/232949A1
The present application includes a process for preparing the (R)- or (S)- enantiomers of 3,4-methylenedioxymethamphetamine ((R)-MDMA or (S)-MDMA) and (R)- or (S)-N-methyl-1,3-benzodioxolylbutanamine ((R)-MBDB or (S)-MBDB) using (R)- tert...  
WO/2022/235906A1
Provided herein are solid forms of alpha-(aminomethyl)-4-(hydroxymethyl)-N-6-isoquinolinyl-(S)- benzeneacetamide mono-tosylate salt ("Compound 1 mono-tosylate"), pharmaceutical compositions containing the solid forms, methods of produci...  
WO/2022/229377A1
The present invention relates to new amphiphilic perfluorinated compounds and their use as a detergent for extracting membrane-proteins or synthesizing membrane-proteins in acellular system. It also relates to a method for extracting a m...  
WO/2022/224835A1
Provided is a compound having a structure represented by general formula (A). (In formula (A), Ar is a C5-20 aromatic ring group constituting a ring, R31 represents a group represented by general formula (1), and R32 is a group represent...  
WO/2022/225019A1
A resist composition containing a base component (A) and a compound (B0) represented by general formula (b0) wherein: Rb0 represents a fused ring group containing a fused ring containing one or more aromatic rings, said fused ring group ...  
WO/2022/220201A1
The present invention provides: an active light-sensitive or radiation-sensitive resin composition which contains a compound represented by general formula (S1) and an acid-decomposable resin; a resist film which is formed using this act...  
WO/2022/214054A1
Provided herein are a conjugate and the preparing method and use thereof. The conjugate of formula 1, M- [ (L1) a- (L2) b- (D) c] 1, wherein M is a biological macromolecule having a nucleophilic functional group, M is linked to L1 with t...  
WO/2022/211812A1
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Human Respiratory Syncytial Virus (HRSV) or Human Metapneumovirus (HMPV) inhibitors. The present i...  
WO/2022/211210A1
The present invention relates to a method for producing a fatty acid alkyl ester sulfonate by using a coffee-derived oil. The fatty acid alkyl ester sulfonate produced by using a coffee-derived oil of the present invention had excellent ...  
WO/2022/201171A1
The present invention discloses polyethyleneamine salts of sulphonyl oleic acid and a 5 hydrocarbon fuel additive composition comprising the same. The said polyethyleneamine salts of sulphonyl oleic acid is made by mixing a sulphonyl ole...  
WO/2022/198855A1
The present invention provides a system for efficiently preparing taurine. The system comprises: a liquid storage unit, configured to store a solution containing an alkali metal salt of taurine prepared by an ethylene oxide method; an io...  
WO/2022/203074A1
Provided is a non-aqueous electrolyte containing a non-aqueous electrosolvent and a lithium salt, wherein the non-aqueous solvent includes a carbonate solvent, the lithium salt contains a fluorine-containing cyclic sulfonylimide salt rep...  
WO/2022/202345A1
The present invention provides: an actinic-ray-sensitive or radiation-sensitive resin composition comprising (A) a resin which decomposes by the action of an acid to increase in polarity and (B) a compound which generates an acid upon ir...  
WO/2022/202402A1
The present invention aims to provide: a production method for a semiconductor substrate that has excellent pattern rectangularity; and a composition for forming a resist underlayer film. The semiconductor substrate production method com...  
WO/2022/195500A1
The present disclosure relates to a process for the preparation of lumateperone tosylate intermediate. The process comprises the conversion of benzyl 6-bromo-5-(2-(methylamino)-2-oxoethyl)-1,3,4,5-tetrahydro-2H -pyrido[4,3-b]indole-2-car...  
WO/2022/194566A1
The present invention relates to the purification of aliphatic taurate amides by liquid-liquid extraction, notably to remove free fatty carboxylic acids. Such aliphatic taurate amides may notably be obtained by reaction of a carboxylic a...  
WO/2022/196001A1
Provided are: a radiation-sensitive resin composition which can be formed into a resist film having satisfactory levels of sensitivity and CDU performance even when a next-generation technology is applied; and a pattern formation method....  
WO/2022/188758A1
The present invention relates to the field of biomedicine; provided are a quinoline compound salt or crystal form, a preparation method therefor, and an application thereof. The quinoline compound is as shown in formula (I), and the prov...  
WO/2022/186264A1
The purpose of the present invention is to provide: a method for producing a fluorine-containing compound, the method using a readily available compound to produce a fluorine-containing compound under relatively mild reaction conditions;...  
WO/2022/178594A1
The present disclosure relates to functionalized amino compounds that can provide inhibitors of C-reactive protein (CRP). The present disclosure also relates to pharmaceutical compositions containing such compounds, methods for using suc...  
WO/2022/181695A1
The purpose of the present disclosure is to provide: a complex of a cell and a material; a method for producing a complex of a cell and a material; and a novel compound that can be used to obtain said complex. In a complex according to...  
WO/2022/172602A1
The present invention addresses the problem of providing an actinic light-sensitive or radiation-sensitive resin composition that exhibits an excellent sensitivity to photoexposure. The present invention also addresses the problem of pro...  
WO/2022/172685A1
Provided are a method for forming a resist pattern having excellent performance including sensitivity during a light exposure process, LWR performance and CDU performance even when a next-generation light exposure technology is applied t...  
WO/2022/158442A1
The present invention provides, as a radioactive halogen-labeled precursor compound that is highly stable and reactive, a compound represented by general formula (II) [in the formula, R1 and R2 each independently represent an alkyl group...  
WO/2022/149462A1
A light-absorbing material according to one embodiment of the present disclosure includes a compound represented by formula (1) as a main component. In formula (1): R1 to R30 are independent of each other and include at least one element...  
WO/2022/149461A1
The nonlinear light absorption material according to one mode of the present disclosure contains, as a main component, a compound represented by formula (1). In formula (1), R1 to R15 each independently include at least one atom selected...  
WO/2022/138603A1
A sulfonate composition production method comprising: reacting a diester (hereinafter, the (A) component) of a prescribed unsaturated carboxylic acid with (C) a sulfonating agent in the presence of (B) at least one solvent selected from ...  
WO/2022/133544A1
Cannabidiol (CBD) cannabinoids and CBD cannabinoid analogues with, inter alia, antimicrobial activity, synthetic methods for the preparation thereof and medical uses and formulations containing same.  
WO/2022/138602A1
The present invention is a sulfonate composition comprising, in predetermined mass ratios, (A) a compound represented by formula (1), (B) an organic solvent, (C) an inorganic metallic compound, and (D) water. (1): ROOC-(CH2)p-CH(SO3M)-CH...  
WO/2022/138659A1
Provided is a method for producing a fluorovinyl ether compound capable of suppressing the generation of by-products. The method for producing a fluorovinyl ether compound of the present invention is a method for producing a fluoroviny...  
WO/2022/129651A1
The present invention provides tyrosinase-inhibiting molecules of general formula (I) and a dermopharmaceutical or cosmetic composition that includes at least one of said tyrosinase-inhibiting molecules.  
WO/2022/123575A1
The present invention pertains to present invention relates to a device comprising conjugate/s, and uses thereof in depleting at least one amine, specifically ammonia from body fluids. The present disclosure further provides systems, app...  
WO/2022/116596A1
The invention relates to a concrete micro-foaming agent. The concrete micro-foaming agent contains the following components in parts by weight: 100-150 parts of a sulfonating agent, 0-100 parts of an alkaline agent, 100-200 parts of a un...  
WO/2022/113814A1
Provided are: a radiation-sensitive resin composition able to exhibit satisfactory levels of sensitivity, LWR performance and CDU performance; a method for forming a pattern; and an onium salt compound. This radiation-sensitive resin com...  
WO/2022/114138A1
Provided is a novel method for producing a (1R,2R,3R,5R,6R)-2-amino-6-fluoro-3-[(4-fluorophenyl)methoxy ]bicycle[3.1.0]hexane-2,6-dicarboxylic acid. This production method is characterized by relying on the conversion from a compound rep...  
WO/2022/099826A1
The present invention relates to a Gemini polyoxyethylene ether succinate surfactant for oil displacement and a preparation method therefor. The present invention is characterized in that the surfactant is a Gemini alkylphenol polyoxyeth...  
WO/2022/099374A1
The present invention relates to a compound of formula (I): or a salt or solvate thereof, combinations comprising same, uses and methods thereof, and kits comprising same.  
WO/2022/102190A1
Provided is a pattern formation method and a radiation-sensitive resin composition that can exhibit a sufficient level of sensitivity and CDU performance in a case in which next-generation technology is applied. A radiation-sensitive r...  
WO/2022/100195A1
The present disclosure provides a method for preparing 2-fluoro-5-methoxybenzenesulfonyl chloride. 3-bromo-4-fluoroanisole is used as a raw material and reacts with a metal or metal reagent to obtain an aryl metal reagent, which then rea...  
WO/2022/090448A1
The present invention relates to a novel acylating reagent, a method for its preparation, and a method of using it for acylating at the N-terminal of a peptide or a protein. The novel acylating reagent may be a compound which comprises 5...  
WO/2022/093797A1
Electrolyte additives for energy storage devices comprising functional epoxides compounds are disclosed. Catalysts may be combined with the functional epoxides to create bi-component electrolyte additive systems, which can be utilized as...  
WO/2022/079595A1
Embodiments of the present disclosure generally relate to processes for converting disulfides to conversion products and to processes for producing cysteic acid. In an embodiment, a process for converting cystine to a conversion product ...  
WO/2022/036060A9
Crystalline forms of salts of Compound I are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.  
WO/2022/072693A1
A process for polymerizing at least one fluoromonomer in an aqueous medium containing initiator and hydrocarbon dispersing agent to form an aqueous dispersion of particles of fluoropolymer. The hydrocarbon dispersing agent comprises a co...  
WO/2022/066678A1
The present invention provides, in part, TES-based lipid compounds of Formula (la), and sub-formulas thereof: or a pharmaceutically acceptable salt thereof. The compounds provided herein can be useful for delivery and expression of mRNA ...  

Matches 101 - 150 out of 9,373